nodes	percent_of_prediction	percent_of_DWPC	metapath
Vismodegib—ALB—Estropipate—osteoporosis	0.0684	0.116	CbGbCtD
Vismodegib—ABCG2—Conjugated Estrogens—osteoporosis	0.0469	0.0797	CbGbCtD
Vismodegib—ABCG2—Estradiol—osteoporosis	0.0412	0.07	CbGbCtD
Vismodegib—CYP2C9—Estropipate—osteoporosis	0.0369	0.0626	CbGbCtD
Vismodegib—CYP2C8—Raloxifene—osteoporosis	0.0353	0.0599	CbGbCtD
Vismodegib—SHH—jaw skeleton—osteoporosis	0.0345	0.374	CbGeAlD
Vismodegib—CYP2C8—Ethinyl Estradiol—osteoporosis	0.0341	0.0578	CbGbCtD
Vismodegib—ALB—Estradiol—osteoporosis	0.0284	0.0482	CbGbCtD
Vismodegib—CYP2C8—Cholecalciferol—osteoporosis	0.0272	0.0462	CbGbCtD
Vismodegib—ABCB1—Ethinyl Estradiol—osteoporosis	0.0231	0.0392	CbGbCtD
Vismodegib—CYP2C19—Cholecalciferol—osteoporosis	0.0228	0.0388	CbGbCtD
Vismodegib—CYP2C8—Estradiol—osteoporosis	0.022	0.0373	CbGbCtD
Vismodegib—SHH—vertebral column—osteoporosis	0.0216	0.234	CbGeAlD
Vismodegib—CYP3A4—Estropipate—osteoporosis	0.0214	0.0364	CbGbCtD
Vismodegib—CYP3A4—Calcitriol—osteoporosis	0.0214	0.0364	CbGbCtD
Vismodegib—SHH—skull—osteoporosis	0.0214	0.232	CbGeAlD
Vismodegib—CYP2C9—Cholecalciferol—osteoporosis	0.019	0.0323	CbGbCtD
Vismodegib—CYP2C19—Estradiol—osteoporosis	0.0184	0.0313	CbGbCtD
Vismodegib—CYP3A4—Ergocalciferol—osteoporosis	0.0171	0.0291	CbGbCtD
Vismodegib—ABCB1—Conjugated Estrogens—osteoporosis	0.0169	0.0287	CbGbCtD
Vismodegib—CYP2C9—Estradiol—osteoporosis	0.0153	0.026	CbGbCtD
Vismodegib—ABCB1—Estradiol—osteoporosis	0.0149	0.0252	CbGbCtD
Vismodegib—CYP3A4—Raloxifene—osteoporosis	0.0143	0.0243	CbGbCtD
Vismodegib—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0138	0.0235	CbGbCtD
Vismodegib—CYP3A4—Cholecalciferol—osteoporosis	0.011	0.0188	CbGbCtD
Vismodegib—CYP3A4—Conjugated Estrogens—osteoporosis	0.0101	0.0172	CbGbCtD
Vismodegib—CYP3A4—Estradiol—osteoporosis	0.0089	0.0151	CbGbCtD
Vismodegib—ORM1—vertebral column—osteoporosis	0.00659	0.0714	CbGeAlD
Vismodegib—SHH—bone marrow—osteoporosis	0.00302	0.0327	CbGeAlD
Vismodegib—SMO—uterus—osteoporosis	0.00249	0.027	CbGeAlD
Vismodegib—ORM1—bone marrow—osteoporosis	0.000923	0.01	CbGeAlD
Vismodegib—ABCG2—uterus—osteoporosis	0.000652	0.00707	CbGeAlD
Vismodegib—ABCG2—bone marrow—osteoporosis	0.000553	0.006	CbGeAlD
Vismodegib—Pain in extremity—Estradiol—osteoporosis	0.000532	0.00281	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Etidronic acid—osteoporosis	0.000521	0.00275	CcSEcCtD
Vismodegib—Nausea—Calcium Acetate—osteoporosis	0.000517	0.00273	CcSEcCtD
Vismodegib—Arthralgia—Estropipate—osteoporosis	0.000516	0.00272	CcSEcCtD
Vismodegib—Myalgia—Estropipate—osteoporosis	0.000516	0.00272	CcSEcCtD
Vismodegib—Connective tissue disorder—Pamidronate—osteoporosis	0.000514	0.00271	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Estropipate—osteoporosis	0.000512	0.0027	CcSEcCtD
Vismodegib—Myalgia—Alendronate—osteoporosis	0.000508	0.00268	CcSEcCtD
Vismodegib—Dyspepsia—Etidronic acid—osteoporosis	0.000503	0.00265	CcSEcCtD
Vismodegib—Arthralgia—Raloxifene—osteoporosis	0.0005	0.00264	CcSEcCtD
Vismodegib—Myalgia—Raloxifene—osteoporosis	0.0005	0.00264	CcSEcCtD
Vismodegib—Alopecia—Ethinyl Estradiol—osteoporosis	0.000499	0.00263	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Raloxifene—osteoporosis	0.000496	0.00262	CcSEcCtD
Vismodegib—Myalgia—Ibandronate—osteoporosis	0.000495	0.00261	CcSEcCtD
Vismodegib—Arthralgia—Ibandronate—osteoporosis	0.000495	0.00261	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Ibandronate—osteoporosis	0.000491	0.00259	CcSEcCtD
Vismodegib—Malnutrition—Ethinyl Estradiol—osteoporosis	0.000491	0.00259	CcSEcCtD
Vismodegib—Constipation—Etidronic acid—osteoporosis	0.000489	0.00258	CcSEcCtD
Vismodegib—Abdominal pain upper—Estradiol—osteoporosis	0.000486	0.00256	CcSEcCtD
Vismodegib—Nervous system disorder—Estropipate—osteoporosis	0.000485	0.00256	CcSEcCtD
Vismodegib—Myalgia—Calcitriol—osteoporosis	0.000484	0.00255	CcSEcCtD
Vismodegib—Breast disorder—Estradiol—osteoporosis	0.000481	0.00254	CcSEcCtD
Vismodegib—Skin disorder—Estropipate—osteoporosis	0.00048	0.00253	CcSEcCtD
Vismodegib—Malnutrition—Risedronate—osteoporosis	0.000479	0.00253	CcSEcCtD
Vismodegib—Back pain—Ethinyl Estradiol—osteoporosis	0.000475	0.00251	CcSEcCtD
Vismodegib—Muscle spasms—Ethinyl Estradiol—osteoporosis	0.000472	0.00249	CcSEcCtD
Vismodegib—Nervous system disorder—Raloxifene—osteoporosis	0.00047	0.00248	CcSEcCtD
Vismodegib—Connective tissue disorder—Zoledronate—osteoporosis	0.000469	0.00248	CcSEcCtD
Vismodegib—Gastrointestinal pain—Etidronic acid—osteoporosis	0.000467	0.00247	CcSEcCtD
Vismodegib—Skin disorder—Raloxifene—osteoporosis	0.000465	0.00245	CcSEcCtD
Vismodegib—Nervous system disorder—Ibandronate—osteoporosis	0.000465	0.00245	CcSEcCtD
Vismodegib—Back pain—Risedronate—osteoporosis	0.000463	0.00244	CcSEcCtD
Vismodegib—Alopecia—Pamidronate—osteoporosis	0.000462	0.00244	CcSEcCtD
Vismodegib—Skin disorder—Ibandronate—osteoporosis	0.000461	0.00243	CcSEcCtD
Vismodegib—Muscle spasms—Risedronate—osteoporosis	0.00046	0.00243	CcSEcCtD
Vismodegib—Nausea—Ergocalciferol—osteoporosis	0.000457	0.00241	CcSEcCtD
Vismodegib—Malnutrition—Pamidronate—osteoporosis	0.000455	0.0024	CcSEcCtD
Vismodegib—Abdominal pain—Etidronic acid—osteoporosis	0.000452	0.00238	CcSEcCtD
Vismodegib—Skin disorder—Calcitriol—osteoporosis	0.000451	0.00238	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Estropipate—osteoporosis	0.000451	0.00238	CcSEcCtD
Vismodegib—Dysgeusia—Pamidronate—osteoporosis	0.000446	0.00235	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Alendronate—osteoporosis	0.000444	0.00234	CcSEcCtD
Vismodegib—Back pain—Pamidronate—osteoporosis	0.00044	0.00232	CcSEcCtD
Vismodegib—Muscle spasms—Pamidronate—osteoporosis	0.000438	0.00231	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Raloxifene—osteoporosis	0.000436	0.0023	CcSEcCtD
Vismodegib—Dyspepsia—Estropipate—osteoporosis	0.000435	0.0023	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Ibandronate—osteoporosis	0.000432	0.00228	CcSEcCtD
Vismodegib—Dyspepsia—Alendronate—osteoporosis	0.000429	0.00226	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Estropipate—osteoporosis	0.000427	0.00225	CcSEcCtD
Vismodegib—Fatigue—Estropipate—osteoporosis	0.000426	0.00225	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Calcitriol—osteoporosis	0.000423	0.00223	CcSEcCtD
Vismodegib—Constipation—Estropipate—osteoporosis	0.000423	0.00223	CcSEcCtD
Vismodegib—Pain—Estropipate—osteoporosis	0.000423	0.00223	CcSEcCtD
Vismodegib—Alopecia—Zoledronate—osteoporosis	0.000422	0.00223	CcSEcCtD
Vismodegib—Dyspepsia—Raloxifene—osteoporosis	0.000422	0.00222	CcSEcCtD
Vismodegib—Dyspepsia—Ibandronate—osteoporosis	0.000417	0.0022	CcSEcCtD
Vismodegib—Constipation—Alendronate—osteoporosis	0.000417	0.0022	CcSEcCtD
Vismodegib—Pain—Alendronate—osteoporosis	0.000417	0.0022	CcSEcCtD
Vismodegib—Weight decreased—Estradiol—osteoporosis	0.000416	0.00219	CcSEcCtD
Vismodegib—Malnutrition—Zoledronate—osteoporosis	0.000416	0.00219	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.000415	0.00219	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Raloxifene—osteoporosis	0.000414	0.00218	CcSEcCtD
Vismodegib—Decreased appetite—Ibandronate—osteoporosis	0.000412	0.00217	CcSEcCtD
Vismodegib—Pain—Raloxifene—osteoporosis	0.00041	0.00216	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Ibandronate—osteoporosis	0.000409	0.00216	CcSEcCtD
Vismodegib—Fatigue—Ibandronate—osteoporosis	0.000409	0.00216	CcSEcCtD
Vismodegib—Arthralgia—Risedronate—osteoporosis	0.000408	0.00215	CcSEcCtD
Vismodegib—Myalgia—Risedronate—osteoporosis	0.000408	0.00215	CcSEcCtD
Vismodegib—Dysgeusia—Zoledronate—osteoporosis	0.000407	0.00215	CcSEcCtD
Vismodegib—Alopecia—Conjugated Estrogens—osteoporosis	0.000406	0.00214	CcSEcCtD
Vismodegib—Pain—Ibandronate—osteoporosis	0.000406	0.00214	CcSEcCtD
Vismodegib—Constipation—Ibandronate—osteoporosis	0.000406	0.00214	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.000405	0.00214	CcSEcCtD
Vismodegib—Pruritus—Etidronic acid—osteoporosis	0.000404	0.00213	CcSEcCtD
Vismodegib—Gastrointestinal pain—Estropipate—osteoporosis	0.000404	0.00213	CcSEcCtD
Vismodegib—Decreased appetite—Calcitriol—osteoporosis	0.000404	0.00213	CcSEcCtD
Vismodegib—Back pain—Zoledronate—osteoporosis	0.000402	0.00212	CcSEcCtD
Vismodegib—Malnutrition—Conjugated Estrogens—osteoporosis	0.0004	0.00211	CcSEcCtD
Vismodegib—Muscle spasms—Zoledronate—osteoporosis	0.0004	0.00211	CcSEcCtD
Vismodegib—Gastrointestinal pain—Alendronate—osteoporosis	0.000398	0.0021	CcSEcCtD
Vismodegib—Pain—Calcitriol—osteoporosis	0.000397	0.00209	CcSEcCtD
Vismodegib—Constipation—Calcitriol—osteoporosis	0.000397	0.00209	CcSEcCtD
Vismodegib—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.000393	0.00207	CcSEcCtD
Vismodegib—Dysgeusia—Conjugated Estrogens—osteoporosis	0.000392	0.00207	CcSEcCtD
Vismodegib—Gastrointestinal pain—Raloxifene—osteoporosis	0.000392	0.00207	CcSEcCtD
Vismodegib—Diarrhoea—Etidronic acid—osteoporosis	0.000391	0.00206	CcSEcCtD
Vismodegib—Abdominal pain—Estropipate—osteoporosis	0.000391	0.00206	CcSEcCtD
Vismodegib—Skin disorder—Ethinyl Estradiol—osteoporosis	0.000389	0.00205	CcSEcCtD
Vismodegib—Gastrointestinal pain—Ibandronate—osteoporosis	0.000388	0.00205	CcSEcCtD
Vismodegib—Myalgia—Pamidronate—osteoporosis	0.000388	0.00204	CcSEcCtD
Vismodegib—Arthralgia—Pamidronate—osteoporosis	0.000388	0.00204	CcSEcCtD
Vismodegib—Back pain—Conjugated Estrogens—osteoporosis	0.000387	0.00204	CcSEcCtD
Vismodegib—Abdominal pain—Alendronate—osteoporosis	0.000385	0.00203	CcSEcCtD
Vismodegib—Muscle spasms—Conjugated Estrogens—osteoporosis	0.000385	0.00203	CcSEcCtD
Vismodegib—Nervous system disorder—Risedronate—osteoporosis	0.000383	0.00202	CcSEcCtD
Vismodegib—Skin disorder—Risedronate—osteoporosis	0.00038	0.002	CcSEcCtD
Vismodegib—Gastrointestinal pain—Calcitriol—osteoporosis	0.00038	0.002	CcSEcCtD
Vismodegib—Abdominal pain—Raloxifene—osteoporosis	0.000379	0.002	CcSEcCtD
Vismodegib—Abdominal pain—Ibandronate—osteoporosis	0.000375	0.00198	CcSEcCtD
Vismodegib—Abdominal pain—Calcitriol—osteoporosis	0.000367	0.00194	CcSEcCtD
Vismodegib—Nervous system disorder—Pamidronate—osteoporosis	0.000364	0.00192	CcSEcCtD
Vismodegib—Vomiting—Etidronic acid—osteoporosis	0.000363	0.00192	CcSEcCtD
Vismodegib—Connective tissue disorder—Estradiol—osteoporosis	0.000362	0.00191	CcSEcCtD
Vismodegib—Rash—Etidronic acid—osteoporosis	0.00036	0.0019	CcSEcCtD
Vismodegib—Dermatitis—Etidronic acid—osteoporosis	0.00036	0.0019	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000356	0.00188	CcSEcCtD
Vismodegib—Asthenia—Estropipate—osteoporosis	0.000355	0.00187	CcSEcCtD
Vismodegib—Arthralgia—Zoledronate—osteoporosis	0.000354	0.00187	CcSEcCtD
Vismodegib—Myalgia—Zoledronate—osteoporosis	0.000354	0.00187	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000352	0.00185	CcSEcCtD
Vismodegib—Pruritus—Estropipate—osteoporosis	0.00035	0.00185	CcSEcCtD
Vismodegib—Asthenia—Alendronate—osteoporosis	0.00035	0.00184	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000346	0.00183	CcSEcCtD
Vismodegib—Fatigue—Ethinyl Estradiol—osteoporosis	0.000346	0.00182	CcSEcCtD
Vismodegib—Pruritus—Alendronate—osteoporosis	0.000345	0.00182	CcSEcCtD
Vismodegib—Dyspepsia—Risedronate—osteoporosis	0.000344	0.00181	CcSEcCtD
Vismodegib—Constipation—Ethinyl Estradiol—osteoporosis	0.000343	0.00181	CcSEcCtD
Vismodegib—Myalgia—Conjugated Estrogens—osteoporosis	0.000341	0.0018	CcSEcCtD
Vismodegib—Arthralgia—Conjugated Estrogens—osteoporosis	0.000341	0.0018	CcSEcCtD
Vismodegib—Asthenia—Ibandronate—osteoporosis	0.00034	0.00179	CcSEcCtD
Vismodegib—Nausea—Etidronic acid—osteoporosis	0.00034	0.00179	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000339	0.00179	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000339	0.00179	CcSEcCtD
Vismodegib—Diarrhoea—Estropipate—osteoporosis	0.000338	0.00178	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Risedronate—osteoporosis	0.000337	0.00178	CcSEcCtD
Vismodegib—Fatigue—Risedronate—osteoporosis	0.000337	0.00178	CcSEcCtD
Vismodegib—Pruritus—Ibandronate—osteoporosis	0.000336	0.00177	CcSEcCtD
Vismodegib—Pain—Risedronate—osteoporosis	0.000334	0.00176	CcSEcCtD
Vismodegib—Constipation—Risedronate—osteoporosis	0.000334	0.00176	CcSEcCtD
Vismodegib—Diarrhoea—Alendronate—osteoporosis	0.000333	0.00176	CcSEcCtD
Vismodegib—Asthenia—Calcitriol—osteoporosis	0.000333	0.00176	CcSEcCtD
Vismodegib—Nervous system disorder—Zoledronate—osteoporosis	0.000333	0.00176	CcSEcCtD
Vismodegib—Skin disorder—Zoledronate—osteoporosis	0.00033	0.00174	CcSEcCtD
Vismodegib—Pruritus—Calcitriol—osteoporosis	0.000328	0.00173	CcSEcCtD
Vismodegib—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000328	0.00173	CcSEcCtD
Vismodegib—Diarrhoea—Raloxifene—osteoporosis	0.000328	0.00173	CcSEcCtD
Vismodegib—Dyspepsia—Pamidronate—osteoporosis	0.000327	0.00172	CcSEcCtD
Vismodegib—Alopecia—Estradiol—osteoporosis	0.000325	0.00172	CcSEcCtD
Vismodegib—Diarrhoea—Ibandronate—osteoporosis	0.000325	0.00171	CcSEcCtD
Vismodegib—Decreased appetite—Pamidronate—osteoporosis	0.000323	0.0017	CcSEcCtD
Vismodegib—ABCB1—uterus—osteoporosis	0.000321	0.00348	CbGeAlD
Vismodegib—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000321	0.00169	CcSEcCtD
Vismodegib—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.00032	0.00169	CcSEcCtD
Vismodegib—Malnutrition—Estradiol—osteoporosis	0.00032	0.00169	CcSEcCtD
Vismodegib—Fatigue—Pamidronate—osteoporosis	0.00032	0.00169	CcSEcCtD
Vismodegib—Gastrointestinal pain—Risedronate—osteoporosis	0.00032	0.00169	CcSEcCtD
Vismodegib—Pain—Pamidronate—osteoporosis	0.000318	0.00168	CcSEcCtD
Vismodegib—Constipation—Pamidronate—osteoporosis	0.000318	0.00168	CcSEcCtD
Vismodegib—Diarrhoea—Calcitriol—osteoporosis	0.000318	0.00168	CcSEcCtD
Vismodegib—Skin disorder—Conjugated Estrogens—osteoporosis	0.000317	0.00167	CcSEcCtD
Vismodegib—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000317	0.00167	CcSEcCtD
Vismodegib—Vomiting—Estropipate—osteoporosis	0.000314	0.00166	CcSEcCtD
Vismodegib—Dysgeusia—Estradiol—osteoporosis	0.000314	0.00165	CcSEcCtD
Vismodegib—Rash—Estropipate—osteoporosis	0.000312	0.00164	CcSEcCtD
Vismodegib—Dermatitis—Estropipate—osteoporosis	0.000312	0.00164	CcSEcCtD
Vismodegib—Back pain—Estradiol—osteoporosis	0.00031	0.00163	CcSEcCtD
Vismodegib—Vomiting—Alendronate—osteoporosis	0.00031	0.00163	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000309	0.00163	CcSEcCtD
Vismodegib—Abdominal pain—Risedronate—osteoporosis	0.000309	0.00163	CcSEcCtD
Vismodegib—Muscle spasms—Estradiol—osteoporosis	0.000308	0.00162	CcSEcCtD
Vismodegib—Rash—Alendronate—osteoporosis	0.000307	0.00162	CcSEcCtD
Vismodegib—Dermatitis—Alendronate—osteoporosis	0.000307	0.00162	CcSEcCtD
Vismodegib—Vomiting—Raloxifene—osteoporosis	0.000305	0.00161	CcSEcCtD
Vismodegib—Gastrointestinal pain—Pamidronate—osteoporosis	0.000304	0.0016	CcSEcCtD
Vismodegib—Rash—Raloxifene—osteoporosis	0.000302	0.00159	CcSEcCtD
Vismodegib—Dermatitis—Raloxifene—osteoporosis	0.000302	0.00159	CcSEcCtD
Vismodegib—Vomiting—Ibandronate—osteoporosis	0.000302	0.00159	CcSEcCtD
Vismodegib—Rash—Ibandronate—osteoporosis	0.000299	0.00158	CcSEcCtD
Vismodegib—Dermatitis—Ibandronate—osteoporosis	0.000299	0.00158	CcSEcCtD
Vismodegib—Dyspepsia—Zoledronate—osteoporosis	0.000299	0.00158	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000298	0.00157	CcSEcCtD
Vismodegib—Vomiting—Calcitriol—osteoporosis	0.000295	0.00156	CcSEcCtD
Vismodegib—Decreased appetite—Zoledronate—osteoporosis	0.000295	0.00156	CcSEcCtD
Vismodegib—Nausea—Estropipate—osteoporosis	0.000294	0.00155	CcSEcCtD
Vismodegib—Abdominal pain—Pamidronate—osteoporosis	0.000294	0.00155	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000293	0.00155	CcSEcCtD
Vismodegib—Rash—Calcitriol—osteoporosis	0.000293	0.00154	CcSEcCtD
Vismodegib—Fatigue—Zoledronate—osteoporosis	0.000293	0.00154	CcSEcCtD
Vismodegib—Dermatitis—Calcitriol—osteoporosis	0.000292	0.00154	CcSEcCtD
Vismodegib—Pain—Zoledronate—osteoporosis	0.00029	0.00153	CcSEcCtD
Vismodegib—Constipation—Zoledronate—osteoporosis	0.00029	0.00153	CcSEcCtD
Vismodegib—Nausea—Alendronate—osteoporosis	0.000289	0.00153	CcSEcCtD
Vismodegib—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000288	0.00152	CcSEcCtD
Vismodegib—Asthenia—Ethinyl Estradiol—osteoporosis	0.000288	0.00152	CcSEcCtD
Vismodegib—Nausea—Raloxifene—osteoporosis	0.000285	0.0015	CcSEcCtD
Vismodegib—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000284	0.0015	CcSEcCtD
Vismodegib—Pruritus—Ethinyl Estradiol—osteoporosis	0.000284	0.0015	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000282	0.00149	CcSEcCtD
Vismodegib—Fatigue—Conjugated Estrogens—osteoporosis	0.000282	0.00149	CcSEcCtD
Vismodegib—Nausea—Ibandronate—osteoporosis	0.000282	0.00149	CcSEcCtD
Vismodegib—Asthenia—Risedronate—osteoporosis	0.00028	0.00148	CcSEcCtD
Vismodegib—Pain—Conjugated Estrogens—osteoporosis	0.000279	0.00147	CcSEcCtD
Vismodegib—Constipation—Conjugated Estrogens—osteoporosis	0.000279	0.00147	CcSEcCtD
Vismodegib—Gastrointestinal pain—Zoledronate—osteoporosis	0.000278	0.00146	CcSEcCtD
Vismodegib—Pruritus—Risedronate—osteoporosis	0.000277	0.00146	CcSEcCtD
Vismodegib—Nausea—Calcitriol—osteoporosis	0.000276	0.00145	CcSEcCtD
Vismodegib—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000274	0.00145	CcSEcCtD
Vismodegib—Myalgia—Estradiol—osteoporosis	0.000273	0.00144	CcSEcCtD
Vismodegib—Arthralgia—Estradiol—osteoporosis	0.000273	0.00144	CcSEcCtD
Vismodegib—ABCB1—bone marrow—osteoporosis	0.000273	0.00296	CbGeAlD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000271	0.00143	CcSEcCtD
Vismodegib—Abdominal pain—Zoledronate—osteoporosis	0.000268	0.00141	CcSEcCtD
Vismodegib—Diarrhoea—Risedronate—osteoporosis	0.000267	0.00141	CcSEcCtD
Vismodegib—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000267	0.00141	CcSEcCtD
Vismodegib—Asthenia—Pamidronate—osteoporosis	0.000267	0.00141	CcSEcCtD
Vismodegib—Pruritus—Pamidronate—osteoporosis	0.000263	0.00139	CcSEcCtD
Vismodegib—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000258	0.00136	CcSEcCtD
Vismodegib—Nervous system disorder—Estradiol—osteoporosis	0.000257	0.00135	CcSEcCtD
Vismodegib—Vomiting—Ethinyl Estradiol—osteoporosis	0.000255	0.00134	CcSEcCtD
Vismodegib—Diarrhoea—Pamidronate—osteoporosis	0.000254	0.00134	CcSEcCtD
Vismodegib—Skin disorder—Estradiol—osteoporosis	0.000254	0.00134	CcSEcCtD
Vismodegib—Rash—Ethinyl Estradiol—osteoporosis	0.000253	0.00133	CcSEcCtD
Vismodegib—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000253	0.00133	CcSEcCtD
Vismodegib—Vomiting—Risedronate—osteoporosis	0.000249	0.00131	CcSEcCtD
Vismodegib—Rash—Risedronate—osteoporosis	0.000246	0.0013	CcSEcCtD
Vismodegib—Dermatitis—Risedronate—osteoporosis	0.000246	0.0013	CcSEcCtD
Vismodegib—Asthenia—Zoledronate—osteoporosis	0.000244	0.00128	CcSEcCtD
Vismodegib—Pruritus—Zoledronate—osteoporosis	0.00024	0.00127	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000238	0.00126	CcSEcCtD
Vismodegib—Nausea—Ethinyl Estradiol—osteoporosis	0.000238	0.00126	CcSEcCtD
Vismodegib—Vomiting—Pamidronate—osteoporosis	0.000236	0.00125	CcSEcCtD
Vismodegib—Asthenia—Conjugated Estrogens—osteoporosis	0.000234	0.00124	CcSEcCtD
Vismodegib—Rash—Pamidronate—osteoporosis	0.000234	0.00124	CcSEcCtD
Vismodegib—Dermatitis—Pamidronate—osteoporosis	0.000234	0.00123	CcSEcCtD
Vismodegib—Diarrhoea—Zoledronate—osteoporosis	0.000232	0.00122	CcSEcCtD
Vismodegib—Nausea—Risedronate—osteoporosis	0.000232	0.00122	CcSEcCtD
Vismodegib—Pruritus—Conjugated Estrogens—osteoporosis	0.000231	0.00122	CcSEcCtD
Vismodegib—Dyspepsia—Estradiol—osteoporosis	0.00023	0.00121	CcSEcCtD
Vismodegib—Decreased appetite—Estradiol—osteoporosis	0.000227	0.0012	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Estradiol—osteoporosis	0.000226	0.00119	CcSEcCtD
Vismodegib—Fatigue—Estradiol—osteoporosis	0.000226	0.00119	CcSEcCtD
Vismodegib—Constipation—Estradiol—osteoporosis	0.000224	0.00118	CcSEcCtD
Vismodegib—Pain—Estradiol—osteoporosis	0.000224	0.00118	CcSEcCtD
Vismodegib—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000224	0.00118	CcSEcCtD
Vismodegib—Nausea—Pamidronate—osteoporosis	0.000221	0.00116	CcSEcCtD
Vismodegib—Vomiting—Zoledronate—osteoporosis	0.000216	0.00114	CcSEcCtD
Vismodegib—Rash—Zoledronate—osteoporosis	0.000214	0.00113	CcSEcCtD
Vismodegib—Gastrointestinal pain—Estradiol—osteoporosis	0.000214	0.00113	CcSEcCtD
Vismodegib—Dermatitis—Zoledronate—osteoporosis	0.000214	0.00113	CcSEcCtD
Vismodegib—Vomiting—Conjugated Estrogens—osteoporosis	0.000208	0.0011	CcSEcCtD
Vismodegib—Abdominal pain—Estradiol—osteoporosis	0.000207	0.00109	CcSEcCtD
Vismodegib—Rash—Conjugated Estrogens—osteoporosis	0.000206	0.00109	CcSEcCtD
Vismodegib—Dermatitis—Conjugated Estrogens—osteoporosis	0.000206	0.00109	CcSEcCtD
Vismodegib—Nausea—Zoledronate—osteoporosis	0.000202	0.00106	CcSEcCtD
Vismodegib—Nausea—Conjugated Estrogens—osteoporosis	0.000194	0.00102	CcSEcCtD
Vismodegib—Asthenia—Estradiol—osteoporosis	0.000188	0.00099	CcSEcCtD
Vismodegib—Pruritus—Estradiol—osteoporosis	0.000185	0.000976	CcSEcCtD
Vismodegib—Diarrhoea—Estradiol—osteoporosis	0.000179	0.000944	CcSEcCtD
Vismodegib—Vomiting—Estradiol—osteoporosis	0.000166	0.000877	CcSEcCtD
Vismodegib—Rash—Estradiol—osteoporosis	0.000165	0.00087	CcSEcCtD
Vismodegib—Dermatitis—Estradiol—osteoporosis	0.000165	0.000869	CcSEcCtD
Vismodegib—Nausea—Estradiol—osteoporosis	0.000155	0.000819	CcSEcCtD
Vismodegib—ALB—Transmembrane transport of small molecules—ANXA2—osteoporosis	5.34e-05	0.000414	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—TLN1—osteoporosis	5.32e-05	0.000412	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—VCL—osteoporosis	5.25e-05	0.000406	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—SPP1—osteoporosis	5.17e-05	0.0004	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	5.16e-05	0.0004	CbGpPWpGaD
Vismodegib—ALB—Selenium Micronutrient Network—IL1B—osteoporosis	5.12e-05	0.000397	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—ADCY5—osteoporosis	5.07e-05	0.000392	CbGpPWpGaD
Vismodegib—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	5.06e-05	0.000392	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	5.03e-05	0.000389	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	4.94e-05	0.000382	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	4.91e-05	0.00038	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—SPP1—osteoporosis	4.9e-05	0.00038	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—IL1B—osteoporosis	4.89e-05	0.000379	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—ANXA2—osteoporosis	4.68e-05	0.000362	CbGpPWpGaD
Vismodegib—ALB—Folate Metabolism—TNF—osteoporosis	4.68e-05	0.000362	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—IRS2—osteoporosis	4.68e-05	0.000362	CbGpPWpGaD
Vismodegib—ALB—Vitamin B12 Metabolism—IL6—osteoporosis	4.64e-05	0.000359	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—LEP—osteoporosis	4.58e-05	0.000354	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—CA2—osteoporosis	4.55e-05	0.000352	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—OXCT1—osteoporosis	4.55e-05	0.000352	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—MGLL—osteoporosis	4.43e-05	0.000343	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—IRS2—osteoporosis	4.43e-05	0.000343	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	4.41e-05	0.000341	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—RAP1A—osteoporosis	4.38e-05	0.00034	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—ESR1—osteoporosis	4.37e-05	0.000338	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—LEP—osteoporosis	4.34e-05	0.000336	CbGpPWpGaD
Vismodegib—ALB—Platelet degranulation—TGFB1—osteoporosis	4.3e-05	0.000333	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	4.2e-05	0.000325	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	4.18e-05	0.000323	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—ESR1—osteoporosis	4.14e-05	0.000321	CbGpPWpGaD
Vismodegib—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	4.1e-05	0.000318	CbGpPWpGaD
Vismodegib—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—osteoporosis	4.09e-05	0.000317	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—IRS1—osteoporosis	4.08e-05	0.000316	CbGpPWpGaD
Vismodegib—CYP2C8—Biological oxidations—POMC—osteoporosis	4.06e-05	0.000314	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	4.02e-05	0.000311	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—FGA—osteoporosis	3.98e-05	0.000308	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—POMC—osteoporosis	3.93e-05	0.000304	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—IRS1—osteoporosis	3.87e-05	0.0003	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—IL6R—osteoporosis	3.84e-05	0.000297	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PKM—osteoporosis	3.83e-05	0.000297	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—FDPS—osteoporosis	3.83e-05	0.000297	CbGpPWpGaD
Vismodegib—ALB—Metabolism—FDPS—osteoporosis	3.81e-05	0.000295	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PKM—osteoporosis	3.81e-05	0.000295	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—TGFB1—osteoporosis	3.8e-05	0.000294	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—IGF1—osteoporosis	3.78e-05	0.000293	CbGpPWpGaD
Vismodegib—ALB—Folate Metabolism—IL6—osteoporosis	3.78e-05	0.000292	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—IDH2—osteoporosis	3.77e-05	0.000292	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	3.75e-05	0.00029	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—POMC—osteoporosis	3.73e-05	0.000289	CbGpPWpGaD
Vismodegib—ALB—Selenium Micronutrient Network—TNF—osteoporosis	3.72e-05	0.000288	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—IL6R—osteoporosis	3.64e-05	0.000282	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PGLS—osteoporosis	3.63e-05	0.000281	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—GPD2—osteoporosis	3.63e-05	0.000281	CbGpPWpGaD
Vismodegib—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	3.63e-05	0.000281	CbGpPWpGaD
Vismodegib—CYP2C19—Biological oxidations—POMC—osteoporosis	3.62e-05	0.000281	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—FGB—osteoporosis	3.62e-05	0.00028	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	3.62e-05	0.00028	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PGLS—osteoporosis	3.61e-05	0.00028	CbGpPWpGaD
Vismodegib—ALB—Metabolism—GPD2—osteoporosis	3.61e-05	0.00028	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—IGF1—osteoporosis	3.58e-05	0.000278	CbGpPWpGaD
Vismodegib—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	3.58e-05	0.000277	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—TNF—osteoporosis	3.55e-05	0.000275	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—CYP27A1—osteoporosis	3.54e-05	0.000274	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—ACP5—osteoporosis	3.45e-05	0.000267	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PKM—osteoporosis	3.42e-05	0.000265	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—FDPS—osteoporosis	3.42e-05	0.000265	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	3.42e-05	0.000265	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—FDPS—osteoporosis	3.34e-05	0.000258	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PKM—osteoporosis	3.34e-05	0.000258	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—ATIC—osteoporosis	3.32e-05	0.000257	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PNP—osteoporosis	3.32e-05	0.000257	CbGpPWpGaD
Vismodegib—CYP2C9—Biological oxidations—POMC—osteoporosis	3.3e-05	0.000256	CbGpPWpGaD
Vismodegib—ALB—Metabolism—ATIC—osteoporosis	3.3e-05	0.000256	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PNP—osteoporosis	3.3e-05	0.000256	CbGpPWpGaD
Vismodegib—ABCG2—Transmembrane transport of small molecules—ADCY5—osteoporosis	3.25e-05	0.000252	CbGpPWpGaD
Vismodegib—SHH—Disease—MYC—osteoporosis	3.25e-05	0.000251	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—GPD2—osteoporosis	3.24e-05	0.000251	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PGLS—osteoporosis	3.24e-05	0.000251	CbGpPWpGaD
Vismodegib—SHH—Disease—TGFB1—osteoporosis	3.24e-05	0.000251	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—TPI1—osteoporosis	3.21e-05	0.000248	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—IGF1—osteoporosis	3.18e-05	0.000246	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—GPD2—osteoporosis	3.16e-05	0.000245	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PGLS—osteoporosis	3.16e-05	0.000245	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	3.13e-05	0.000242	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PKM—osteoporosis	3.12e-05	0.000241	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—FDPS—osteoporosis	3.12e-05	0.000241	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—P4HB—osteoporosis	3.01e-05	0.000233	CbGpPWpGaD
Vismodegib—ALB—Selenium Micronutrient Network—IL6—osteoporosis	3e-05	0.000232	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—ATIC—osteoporosis	2.96e-05	0.00023	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PNP—osteoporosis	2.96e-05	0.00023	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—GAPDH—osteoporosis	2.96e-05	0.000229	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PGLS—osteoporosis	2.95e-05	0.000229	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—GPD2—osteoporosis	2.95e-05	0.000229	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PNP—osteoporosis	2.89e-05	0.000224	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—ATIC—osteoporosis	2.89e-05	0.000224	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—IL6—osteoporosis	2.89e-05	0.000224	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—RAP1A—osteoporosis	2.88e-05	0.000223	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—OXCT1—osteoporosis	2.82e-05	0.000219	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—CA2—osteoporosis	2.82e-05	0.000219	CbGpPWpGaD
Vismodegib—ALB—Metabolism—CA2—osteoporosis	2.81e-05	0.000217	CbGpPWpGaD
Vismodegib—ALB—Metabolism—OXCT1—osteoporosis	2.81e-05	0.000217	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—MGLL—osteoporosis	2.75e-05	0.000213	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—IL6—osteoporosis	2.74e-05	0.000212	CbGpPWpGaD
Vismodegib—ALB—Metabolism—MGLL—osteoporosis	2.74e-05	0.000212	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—ATIC—osteoporosis	2.7e-05	0.000209	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PNP—osteoporosis	2.7e-05	0.000209	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.59e-05	0.000201	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.58e-05	0.0002	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CA2—osteoporosis	2.52e-05	0.000195	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—OXCT1—osteoporosis	2.52e-05	0.000195	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CA2—osteoporosis	2.46e-05	0.00019	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—OXCT1—osteoporosis	2.46e-05	0.00019	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—MGLL—osteoporosis	2.46e-05	0.00019	CbGpPWpGaD
Vismodegib—SHH—Disease—IL6—osteoporosis	2.44e-05	0.000189	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—MGLL—osteoporosis	2.4e-05	0.000186	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—IDH2—osteoporosis	2.34e-05	0.000181	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—ENO1—osteoporosis	2.33e-05	0.00018	CbGpPWpGaD
Vismodegib—ALB—Metabolism—IDH2—osteoporosis	2.33e-05	0.00018	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.32e-05	0.000179	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—OXCT1—osteoporosis	2.3e-05	0.000178	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CA2—osteoporosis	2.3e-05	0.000178	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—PSMA5—osteoporosis	2.29e-05	0.000178	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—PSMA2—osteoporosis	2.29e-05	0.000178	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—MYC—osteoporosis	2.27e-05	0.000176	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—TGFB1—osteoporosis	2.27e-05	0.000176	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—MGLL—osteoporosis	2.24e-05	0.000173	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—CYP27A1—osteoporosis	2.2e-05	0.00017	CbGpPWpGaD
Vismodegib—ALB—Metabolism—CYP27A1—osteoporosis	2.19e-05	0.000169	CbGpPWpGaD
Vismodegib—CYP3A4—Biological oxidations—POMC—osteoporosis	2.18e-05	0.000169	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—MYC—osteoporosis	2.15e-05	0.000167	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—TGFB1—osteoporosis	2.15e-05	0.000166	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—ACP5—osteoporosis	2.14e-05	0.000166	CbGpPWpGaD
Vismodegib—ALB—Metabolism—ACP5—osteoporosis	2.13e-05	0.000165	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.11e-05	0.000164	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.11e-05	0.000164	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.1e-05	0.000163	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—IDH2—osteoporosis	2.09e-05	0.000162	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PKM—osteoporosis	2.06e-05	0.000159	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—FDPS—osteoporosis	2.06e-05	0.000159	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—IDH2—osteoporosis	2.04e-05	0.000158	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—ADCY5—osteoporosis	2e-05	0.000155	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—TPI1—osteoporosis	1.99e-05	0.000154	CbGpPWpGaD
Vismodegib—ALB—Metabolism—TPI1—osteoporosis	1.98e-05	0.000153	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CYP27A1—osteoporosis	1.96e-05	0.000152	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PGLS—osteoporosis	1.95e-05	0.000151	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GPD2—osteoporosis	1.95e-05	0.000151	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CYP27A1—osteoporosis	1.92e-05	0.000148	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—ACP5—osteoporosis	1.91e-05	0.000148	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	1.91e-05	0.000148	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—IDH2—osteoporosis	1.9e-05	0.000147	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.89e-05	0.000146	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	1.88e-05	0.000146	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	1.88e-05	0.000145	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—P4HB—osteoporosis	1.87e-05	0.000145	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—ACP5—osteoporosis	1.86e-05	0.000144	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—CYP19A1—osteoporosis	1.86e-05	0.000144	CbGpPWpGaD
Vismodegib—ALB—Metabolism—P4HB—osteoporosis	1.86e-05	0.000144	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—GAPDH—osteoporosis	1.84e-05	0.000142	CbGpPWpGaD
Vismodegib—ALB—Metabolism—GAPDH—osteoporosis	1.83e-05	0.000141	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CYP27A1—osteoporosis	1.79e-05	0.000139	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—RAP1A—osteoporosis	1.79e-05	0.000138	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ATIC—osteoporosis	1.78e-05	0.000138	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PNP—osteoporosis	1.78e-05	0.000138	CbGpPWpGaD
Vismodegib—ALB—Metabolism—RAP1A—osteoporosis	1.78e-05	0.000138	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—TPI1—osteoporosis	1.78e-05	0.000137	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.76e-05	0.000136	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	1.75e-05	0.000136	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—ACP5—osteoporosis	1.74e-05	0.000135	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—TPI1—osteoporosis	1.73e-05	0.000134	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.72e-05	0.000133	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—IL6—osteoporosis	1.71e-05	0.000132	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—P4HB—osteoporosis	1.67e-05	0.000129	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—GAPDH—osteoporosis	1.64e-05	0.000127	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—IGF1—osteoporosis	1.64e-05	0.000127	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—P4HB—osteoporosis	1.63e-05	0.000126	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—IL6—osteoporosis	1.62e-05	0.000125	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—TPI1—osteoporosis	1.62e-05	0.000125	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—GAPDH—osteoporosis	1.6e-05	0.000124	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—RAP1A—osteoporosis	1.6e-05	0.000124	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.56e-05	0.000121	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—RAP1A—osteoporosis	1.56e-05	0.000121	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.55e-05	0.00012	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—P4HB—osteoporosis	1.52e-05	0.000118	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—ADCY5—osteoporosis	1.52e-05	0.000118	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—GPX1—osteoporosis	1.52e-05	0.000117	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CA2—osteoporosis	1.52e-05	0.000117	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—OXCT1—osteoporosis	1.52e-05	0.000117	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—GAPDH—osteoporosis	1.49e-05	0.000116	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—MGLL—osteoporosis	1.48e-05	0.000114	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—RAP1A—osteoporosis	1.46e-05	0.000113	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—ENO1—osteoporosis	1.45e-05	0.000112	CbGpPWpGaD
Vismodegib—ALB—Metabolism—ENO1—osteoporosis	1.44e-05	0.000111	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PSMA2—osteoporosis	1.42e-05	0.00011	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PSMA5—osteoporosis	1.42e-05	0.00011	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PSMA2—osteoporosis	1.42e-05	0.00011	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PSMA5—osteoporosis	1.42e-05	0.00011	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—MTHFR—osteoporosis	1.4e-05	0.000108	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.39e-05	0.000108	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—ENO1—osteoporosis	1.29e-05	9.99e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PSMA2—osteoporosis	1.27e-05	9.84e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PSMA5—osteoporosis	1.27e-05	9.84e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.27e-05	9.83e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—ENO1—osteoporosis	1.26e-05	9.75e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—IDH2—osteoporosis	1.26e-05	9.72e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PSMA2—osteoporosis	1.24e-05	9.61e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PSMA5—osteoporosis	1.24e-05	9.61e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.18e-05	9.14e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—ENO1—osteoporosis	1.18e-05	9.11e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PSMA2—osteoporosis	1.16e-05	8.98e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PSMA5—osteoporosis	1.16e-05	8.98e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—CYP19A1—osteoporosis	1.16e-05	8.95e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—CYP19A1—osteoporosis	1.15e-05	8.9e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ACP5—osteoporosis	1.15e-05	8.89e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—POMC—osteoporosis	1.12e-05	8.66e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—TPI1—osteoporosis	1.07e-05	8.27e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CYP19A1—osteoporosis	1.03e-05	7.99e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CYP19A1—osteoporosis	1.01e-05	7.79e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—P4HB—osteoporosis	1e-05	7.77e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GAPDH—osteoporosis	9.85e-06	7.63e-05	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—TGFB1—osteoporosis	9.82e-06	7.6e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—RAP1A—osteoporosis	9.6e-06	7.43e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—ADCY5—osteoporosis	9.44e-06	7.31e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—GPX1—osteoporosis	9.41e-06	7.29e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CYP19A1—osteoporosis	9.4e-06	7.28e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—ADCY5—osteoporosis	9.39e-06	7.27e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—GPX1—osteoporosis	9.35e-06	7.24e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—MTHFR—osteoporosis	8.68e-06	6.72e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—MTHFR—osteoporosis	8.63e-06	6.69e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—ADCY5—osteoporosis	8.43e-06	6.53e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—GPX1—osteoporosis	8.4e-06	6.5e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—ADCY5—osteoporosis	8.22e-06	6.37e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—GPX1—osteoporosis	8.2e-06	6.35e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ENO1—osteoporosis	7.76e-06	6.01e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—MTHFR—osteoporosis	7.75e-06	6e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—ADCY5—osteoporosis	7.68e-06	5.95e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—GPX1—osteoporosis	7.66e-06	5.93e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PSMA2—osteoporosis	7.64e-06	5.92e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PSMA5—osteoporosis	7.64e-06	5.92e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—MTHFR—osteoporosis	7.56e-06	5.86e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—MTHFR—osteoporosis	7.07e-06	5.47e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—POMC—osteoporosis	6.94e-06	5.38e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—POMC—osteoporosis	6.9e-06	5.35e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CYP19A1—osteoporosis	6.2e-06	4.8e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—POMC—osteoporosis	6.2e-06	4.8e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—POMC—osteoporosis	6.05e-06	4.68e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—POMC—osteoporosis	5.65e-06	4.38e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ADCY5—osteoporosis	5.07e-06	3.92e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GPX1—osteoporosis	5.05e-06	3.91e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—MTHFR—osteoporosis	4.66e-06	3.61e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—POMC—osteoporosis	3.73e-06	2.89e-05	CbGpPWpGaD
